All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Reported results | 2016-002067-33 | COBALT: Coversin Global Study: An Open-Label, Safety and Efficacy Trial in PNH Patients | 2017-12-21 | due-trials |
| Reported results Terminated | 2016-004129-18 | CONSERVE: Coversin Long Term Safety and Efficacy Surveillance Study | 2020-06-22 | due-trials |
| Reported results Terminated | 2017-000064-15 | A Phase 2, single arm study of Safety and Efficacy of Coversin in adult aHUS subjects | 2019-04-17 | due-trials |
| Exempt, with results Terminated | 2017-002835-40 | Topical rVA576 for treatment of atopic keratoconjunctivitis: a randomised placebo double masked parallel trial (TRACKER) rVA576 tópico para el tratamiento de la queratoconjuntivitis atópica: un ens... | 2020-12-15 | not-yet-due |
| Reported results | 2017-002836-18 | A Phase IIa open label single arm study of safety and efficacy of rVA576 in adult mild to moderate Bullous Pemphigoid subjects | 2020-04-29 | due-trials |
| Reported results | 2017-003847-39 | CAPSTONE: Phase III Confirmatory Assessment Protocol: rVA576 Safety and Efficacy in Three-Part, Two-Arm, Randomised Open Label Evaluation in patients with Paroxysmal Nocturnal Haemoglobinuria (PNH) | 2020-09-03 | due-trials |
| Listed as ongoing, but also has a completion date | 2020-000086-17 | Multicentre Study of nomacopan in Paediatric Haematopoietic Stem-Cell Transplant Associated Thrombotic Microangiopathy | 2024-05-15 | bad-data |
| Ongoing, reported early | 2020-005987-67 | A randomized, part A partial blinded and part B double blinded, placebo-controlled 24-week clinical study to evaluate the efficacy and safety of nomacopan therapy in adult patients with bullous pemphi... | not-yet-due |